Bone Biologics (BBLG) Enterprise Value (QoQ) (2013 - 2025)
Bone Biologics (BBLG) Enterprise Value (QoQ) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Bone Biologics |
1.47 Mn |
1.47 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
11.82% |
| Sep 30, 2025 |
8.91% |
| Jun 30, 2025 |
-141.77% |
| Mar 31, 2025 |
17.40% |
| Dec 31, 2024 |
6.77% |
| Sep 30, 2024 |
-52.93% |
| Jun 30, 2024 |
27.75% |
| Mar 31, 2024 |
-6.64% |
| Dec 31, 2023 |
32.03% |
| Sep 30, 2023 |
36.46% |
| Jun 30, 2023 |
-13.24% |
| Mar 31, 2023 |
17.91% |
| Dec 31, 2022 |
-49.00% |
| Sep 30, 2022 |
7.25% |
| Jun 30, 2022 |
6.19% |
| Mar 31, 2022 |
12.89% |
| Dec 31, 2021 |
-197,747.21% |
| Sep 30, 2021 |
23.97% |
| Jun 30, 2021 |
93.76% |
| Mar 31, 2020 |
89.93% |
